首页> 外文OA文献 >Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

【2h】

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

机译：使用MCF10A / MCF10CA1a乳腺癌进展细胞系模型研究活性，突变形式的EGFR在乳腺癌发展和吉非替尼治疗中的作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background

机译：背景

著录项

作者
Bessette Darrell C.; Tilch Erik; Seidens Tatjana; Quinn Michael C. J.; Wiegmans Adrian P.; Shi Wei; Cocciardi Sibylle; McCart-Reed Amy; Saunus Jodi M.; Simpson Peter T.; Grimmond Sean M.; Lakhani Sunil R.; Khanna Kum Kum; Waddell Nic; Al-Ejeh Fares; Chevenvix-Trench Georgia;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. The Function of Vacuolar ATPase (V-ATPase) a Subunit Isoforms in Invasiveness of MCF10a and MCF10CA1a Human Breast Cancer Cells [J] . Joseph Capecci, Michael Forgac The Journal of biological chemistry . 2013,第45期

机译：真空ATP酶（V-ATP酶）的功能在MCF10A和MCF10CA1A人乳腺癌细胞侵袭性中的亚基同种型
2. The scaffolding protein NHERF1 sensitizes EGFR-dependent tumor growth, motility and invadopodia function to gefitinib treatment in breast cancer cells [J] . Antonia Bellizzi, Maria Raffaella Greco, Rosa Rubino, International journal of oncology . 2014,第3期

机译：支架蛋白NHERF1使EGFR依赖性肿瘤生长，运动和侵染功能对吉非替尼治疗乳腺癌细胞敏感
3. Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancer [J] . Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Eugeni López-Bonet, International journal of oncology . 2008,第6期

机译：抗EGFR的西妥昔单抗和DNA交联剂顺铂在耐吉非替尼的MDA-MB-468细胞中的生长和分子相互作用：治疗三阴性/基础性乳腺癌的新前景
4. Development and validation of a radiomics nomogram for progression-free survival prediction in stage IV EGFR-mutant non-small cell lung cancer [C] . Jiangdian Song, Yali Zang, Weimin Li, Conference on Computer-Aided Diagnosis . 2017

机译：放射组学诺模图的开发和验证，用于IV期EGFR突变非小细胞肺癌的无进展生存期预测
5. Determining the role of p53 mutation in human breast cancer progression using recombinant mutant/wild-type p53 heterozygous human mammary epithelial cell culture models. [D] . Junk, Damian Jerome. 2008

机译：使用重组突变体/野生型p53杂合性人类乳腺上皮细胞培养模型确定p53突变在人类乳腺癌进展中的作用。
6. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib [O] . Darrell C. Bessette, Erik Tilch, Tatjana Seidens, -1

机译：使用MCF10A / MCF10CA1a乳腺癌进展细胞系模型研究活性突变形式的EGFR在吉非替尼治疗乳腺癌发展和治疗中的作用
7. Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib. [O] . Darrell C Bessette, Erik Tilch, Tatjana Seidens, 2015

机译：使用mCF10a / mCF10Ca1a乳腺癌进展细胞系模型研究活性，突变形式的EGFR在乳腺癌发展和治疗中的作用吉非替尼。

Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅